AIM ImmunoTech Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was USD 0.046 million compared to USD 0.021 million a year ago. Net loss was USD 7.82 million compared to USD 6.39 million a year ago. Basic loss per share from continuing operations was USD 0.16 compared to USD 0.13 a year ago.
For the nine months, revenue was USD 0.137 million compared to USD 0.085 million a year ago. Net loss was USD 16.39 million compared to USD 15.06 million a year ago. Basic loss per share from continuing operations was USD 0.34 compared to USD 0.31 a year ago.